Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

Malcolm Brenner; Helen Heslop; Robert Krance; Marc Horowitz; Douglas Strother; Jed Nuchtern; Bambi Grilley; Edith Martingano; Kristine Cooper

doi:10.1089/10430340050057549

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

Malcolm Brenner, Helen Heslop, Robert Krance, Marc Horowitz, Douglas Strother, Jed Nuchtern, Bambi Grilley, Edith Martingano, Kristine Cooper

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Original language	English (US)
Pages (from-to)	1477-1488
Number of pages	12
Journal	Human Gene Therapy
Volume	11
Issue number	10
DOIs	https://doi.org/10.1089/10430340050057549
State	Published - Jul 1 2000

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/10430340050057549

Cite this

Brenner, M., Heslop, H., Krance, R., Horowitz, M., Strother, D., Nuchtern, J., Grilley, B., Martingano, E., & Cooper, K. (2000). Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. Human Gene Therapy, 11(10), 1477-1488. https://doi.org/10.1089/10430340050057549

Brenner, M , Heslop, H, Krance, R, Horowitz, M, Strother, D, Nuchtern, J, Grilley, B, Martingano, E & Cooper, K 2000, 'Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector', Human Gene Therapy, vol. 11, no. 10, pp. 1477-1488. https://doi.org/10.1089/10430340050057549

@article{dd94510337864ef2ad332cddfae0b317,

title = "Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector",

author = "Malcolm Brenner and Helen Heslop and Robert Krance and Marc Horowitz and Douglas Strother and Jed Nuchtern and Bambi Grilley and Edith Martingano and Kristine Cooper",

year = "2000",

month = jul,

day = "1",

doi = "10.1089/10430340050057549",

language = "English (US)",

volume = "11",

pages = "1477--1488",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "10",

}

TY - JOUR

T1 - Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

AU - Brenner, Malcolm

AU - Heslop, Helen

AU - Krance, Robert

AU - Horowitz, Marc

AU - Strother, Douglas

AU - Nuchtern, Jed

AU - Grilley, Bambi

AU - Martingano, Edith

AU - Cooper, Kristine

PY - 2000/7/1

Y1 - 2000/7/1

UR - http://www.scopus.com/inward/record.url?scp=0034235950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235950&partnerID=8YFLogxK

U2 - 10.1089/10430340050057549

DO - 10.1089/10430340050057549

M3 - Review article

C2 - 10910144

AN - SCOPUS:0034235950

SN - 1043-0342

VL - 11

SP - 1477

EP - 1488

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 10

ER -

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this